Chondrocalcinosis 2 (CCAL2) Print

Back to All Tests
Order Test
Gene
ANKH
MIM
118600
Clinical Description

Chondrocalcinosis 2

Chondrocalcinosis 2 (CCAL2; MIM 118600), also known as calcium pyrophosphate dihydrate deposition disease (CPPDD), is an autosomal dominant disorder caused by mutations in the ANKH gene. In general, chondrocalcinosis is characterized by the deposition of calcium containing crystals in joints which can cause recurrent acute attacks of joint pain and synovitis (pseudogout). If chronic, this can lead to degenerative joint disease. Chondrocalcinosis 2 is typically polyarticular in nature and has an earlier age of onset, during the third or fourth decade, compared to other types of chondrocalcinosis. The calcium containing crystals in chondrocalcinosis 2 are composed of calcium pyrophosphate dihydrate (CPPD). Patients with chondrocalcinosis 2 usually do not display extraarticular calcifications. Chondrocalcinosis 2 is allelic to autosomal dominant craniometaphyseal dysplasia (MIM 123000). Some members of one family with a defined ANKH mutation have features of both chondrocalcinosis 2 and craniometaphyseal dysplasia.

Available Tests
The following test(s) are available for Chondrocalcinosis 2 (CCAL2)
DNA Sequencing
Price: $1,340
CPT Codes: 83890 83898 83894 83904 83912
  1 15 15 22 1
Back to All Tests
Order Test

Suggest a Test

Our list of diagnostics continues to expand to meet your needs. Please let us know if you require an additional test by completing our online Suggest a Test form.

Feedback

Comment on our website, let us know how we did on your last test or complete a brief survey. Submit your feedback now.